tradingkey.logo

Niagen Bioscience Inc

NAGE
5.200USD
+0.070+1.36%
Handelsschluss 02/06, 16:00ETKurse um 15 Minuten verzögert
414.12MMarktkapitalisierung
19.83KGV TTM

Niagen Bioscience Inc

5.200
+0.070+1.36%

mehr Informationen über Niagen Bioscience Inc Unternehmen

Niagen Bioscience, Inc., formerly Chromadex Corp., is a global bioscience company. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that is a key regulator of cellular metabolism and is found in every cell of the human body. The Company’s Consumer Products segment provides finished dietary supplement products that contain the Company's proprietary ingredients directly to consumers and distributors and offers NAD+ test kits exclusively to healthcare practitioners. The Ingredients segment develops and commercializes proprietary-based ingredient technologies, including food-grade Niagen and pharmaceutical-grade Niagen, and supplies these ingredients as raw materials to the manufacturers of consumer products and United States FDA-registered 503B outsourcing facilities, respectively. The Analytical Reference Standards and Services segment offers the supply of phytochemical reference standards and other research and development services.

Niagen Bioscience Inc Informationen

BörsenkürzelNAGE
Name des UnternehmensNiagen Bioscience Inc
IPO-datumJun 25, 2007
CEOFried (Robert N)
Anzahl der mitarbeiter104
WertpapierartOrdinary Share
GeschäftsjahresendeJun 25
Addresse10900 Wilshire Blvd Suite 600
StadtLOS ANGELES
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl90024
Telefon13103886706
Websitehttps://www.niagenbioscience.com/
BörsenkürzelNAGE
IPO-datumJun 25, 2007
CEOFried (Robert N)

Führungskräfte von Niagen Bioscience Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ozan Pamir
Mr. Ozan Pamir
Chief Financial Officer
Chief Financial Officer
7.37K
+4465.00%
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Lead Independent Director
Lead Independent Director
7.00K
--
Mr. Carlos Luis Lopez
Mr. Carlos Luis Lopez
Senior Vice President, General Counsel
Senior Vice President, General Counsel
2.25K
--
Mr. Frank L. Jaksch, Jr.
Mr. Frank L. Jaksch, Jr.
Chairman of the Board
Chairman of the Board
--
--
Mr. Robert N. (Rob) Fried
Mr. Robert N. (Rob) Fried
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Wendy Yu
Ms. Wendy Yu
Independent Director
Independent Director
--
--
Mr. Gary Ng
Mr. Gary Ng
Independent Director
Independent Director
--
--
Ms. Kristin Patrick
Ms. Kristin Patrick
Independent Director
Independent Director
--
--
Ms. Ann Cohen
Ms. Ann Cohen
Independent Director
Independent Director
--
--
Mr. Hamed Shahbazi
Mr. Hamed Shahbazi
Independent Director
Independent Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Ozan Pamir
Mr. Ozan Pamir
Chief Financial Officer
Chief Financial Officer
7.37K
+4465.00%
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Mr. Steven D. (Steve) Rubin, Esq., J.D.
Lead Independent Director
Lead Independent Director
7.00K
--
Mr. Carlos Luis Lopez
Mr. Carlos Luis Lopez
Senior Vice President, General Counsel
Senior Vice President, General Counsel
2.25K
--
Mr. Frank L. Jaksch, Jr.
Mr. Frank L. Jaksch, Jr.
Chairman of the Board
Chairman of the Board
--
--
Mr. Robert N. (Rob) Fried
Mr. Robert N. (Rob) Fried
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Wendy Yu
Ms. Wendy Yu
Independent Director
Independent Director
--
--

Umsatzaufteilung

Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Sun, Nov 16
Aktualisiert: Sun, Nov 16
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Brilliant Dynasty Ltd
14.30%
Pioneer Step Holdings, Ltd.
8.67%
Nestle Health Science US Holdings, Inc.
4.78%
BlackRock Institutional Trust Company, N.A.
4.37%
The Vanguard Group, Inc.
4.10%
Andere
63.78%
Aktionäre
Aktionäre
Anteil
Brilliant Dynasty Ltd
14.30%
Pioneer Step Holdings, Ltd.
8.67%
Nestle Health Science US Holdings, Inc.
4.78%
BlackRock Institutional Trust Company, N.A.
4.37%
The Vanguard Group, Inc.
4.10%
Andere
63.78%
Aktionärstypen
Aktionäre
Anteil
Corporation
31.56%
Investment Advisor
18.38%
Investment Advisor/Hedge Fund
14.02%
Hedge Fund
5.69%
Individual Investor
2.44%
Research Firm
1.39%
Pension Fund
0.90%
Bank and Trust
0.23%
Venture Capital
0.07%
Andere
25.31%

Institutionelle Beteiligung

Aktualisiert: Wed, Jan 21
Aktualisiert: Wed, Jan 21
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2026Q4
281
32.87M
38.95%
--
2025Q4
310
32.39M
40.58%
-1.07M
2025Q3
277
29.97M
37.55%
+806.79K
2025Q2
256
54.09M
67.83%
+1.52M
2025Q1
248
52.79M
67.45%
+991.43K
2024Q4
227
50.32M
64.79%
+3.69M
2024Q3
187
45.29M
58.88%
-2.22M
2024Q2
176
44.12M
58.29%
+362.19K
2024Q1
173
40.79M
55.40%
+2.41M
2023Q4
177
39.03M
53.11%
+1.29M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Brilliant Dynasty Ltd
11.41M
14.3%
+11.41M
--
Aug 20, 2024
Pioneer Step Holdings, Ltd.
6.92M
8.67%
--
--
Aug 20, 2024
Nestle Health Science US Holdings, Inc.
3.82M
4.78%
--
--
Apr 25, 2025
BlackRock Institutional Trust Company, N.A.
3.49M
4.37%
+46.75K
+1.36%
Sep 30, 2025
The Vanguard Group, Inc.
4.01M
5.02%
+83.42K
+2.13%
Sep 30, 2025
Black Sheep, FLP
2.08M
2.6%
--
--
Apr 25, 2025
Tieton Capital Management, LLC
1.65M
2.06%
+65.61K
+4.15%
Sep 30, 2025
Fried (Robert N)
1.65M
2.06%
+66.67K
+4.22%
Apr 25, 2025
Arrowstreet Capital, Limited Partnership
1.44M
1.8%
+317.42K
+28.36%
Sep 30, 2025
UBS Financial Services, Inc.
1.20M
1.5%
+1.12M
+1541.73%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
AdvisorShares Insider Advantage ETF
0.98%
Gabelli Love Our Planet & People ETF
0.27%
ALPS Barron's 400 ETF
0.2%
Even Herd Long Short ETF
0.11%
Principal U.S. Small-Cap ETF
0.08%
iShares Micro-Cap ETF
0.08%
Vanguard US Quality Factor ETF
0.07%
Vanguard US Momentum Factor ETF
0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.06%
WisdomTree US SmallCap Quality Growth Fund
0.06%
Mehr Anzeigen
AdvisorShares Insider Advantage ETF
Anteil0.98%
Gabelli Love Our Planet & People ETF
Anteil0.27%
ALPS Barron's 400 ETF
Anteil0.2%
Even Herd Long Short ETF
Anteil0.11%
Principal U.S. Small-Cap ETF
Anteil0.08%
iShares Micro-Cap ETF
Anteil0.08%
Vanguard US Quality Factor ETF
Anteil0.07%
Vanguard US Momentum Factor ETF
Anteil0.06%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.06%
WisdomTree US SmallCap Quality Growth Fund
Anteil0.06%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI